Pcaf modulates polyglutamine pathology in a Drosophila model of Huntington's disease

Neurodegenerative Diseases

Volumn 9, Issue 2, 2012, Pages 104-106

  Bodai, Laszlo ^a,c   Pallos, Judit ^a   Thompson, Leslie Michels ^b   Marsh, J Lawrence ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Drosophila; Histone acetyltransferase; Huntington's disease; Nejire; Pcaf; Polyglutamine

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; HUNTINGTIN; MUTANT PROTEIN; POLYGLUTAMINE;

ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DROSOPHILA; GENE INTERACTION; GENE LOSS; GENE OVEREXPRESSION; HUNTINGTON CHOREA; NONHUMAN; PHENOTYPE; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FAMILY; TRANSGENIC ORGANISM;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; HISTONE ACETYLTRANSFERASES; HUNTINGTON DISEASE; IMMUNOBLOTTING; NERVE DEGENERATION; PEPTIDES;

EID: 84856712341     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000330505     Document Type: Article

References (10)

1. Riley BE, Orr HT: Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle. Genes Dev 2006; 20: 2183-2192.
2. Bodai L, Pallos J, Thompson LM, Marsh JL: Altered protein acetylation in polyglutamine diseases. Curr Med Chem 2003; 10: 2577-2587. (Pubitemid 37456027)
3. Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald M, Kurokawa R, Housman DE, Jackson GR, Marsh JL, Thompson LM: Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 2001; 413: 739-743. (Pubitemid 33009952)
4. Cong S, Pepers BA, Evert BO, Rubinsztein DC, Roos RAC, van Ommen GB, Dorsman JC: Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Mol Cell Neurosci 2005; 30: 560-571.
5. Jiang H, Poirier MA, Liang Y, Pei Z, Weiskittel CE, Smith WW, DeFranco DB, Ross CA: Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin. Neurobiol Dis 2006; 23: 543-551. (Pubitemid 44234090)
6. Pallos J, Bodai L, Lukacsovich T, Purcell JM, Steffan JS, Thompson LM, Marsh JL: Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease. Hum Mol Genet 2008; 17: 3767-3775.
7. Hockly E, Richon VM, Woodman B, Smith DL, Zhou X, Rosa E, Sathasivam K, Ghazi-Noori S, Mahal A, Lowden PAS, Steffan JS, Marsh JL, Thompson LM, Lewis CM, Marks PA, Bates GP: Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci USA 2003; 100: 2041-2046. (Pubitemid 36254570)
8. Sterner DE, Berger SL. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 2000; 64: 435-459. (Pubitemid 30412680)
9. Nagy Z, Tora L: Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene 2007; 26: 5341-5357. (Pubitemid 47255920)
10. Lebedeva LA, Nabirochkina EN, Kurshakova MM, Robert F, Krasnov AN, Evgenev MB, Kadonaga JT, Georgieva SG, Tora L: Occupancy of the Drosophila hsp70 promoter by a subset of basal transcription factors diminishes upon transcriptional activation. Proc Natl Acad Sci USA 2005; 102: 18087-18092. (Pubitemid 41798506)